NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma
Hoi-Wing Leung(Chinese University of Hong Kong), Terence K. Lee(Hong Kong Polytechnic University), Victor Ma(Queen Elizabeth Hospital), Etienne Ho Kit Mok(University of British Columbia), Martina Mang Leng Lei(Hong Kong Polytechnic University), Stephanie Ma(University of Hong Kong - Shenzhen Hospital), William C. Cho(Queen Elizabeth Hospital), Irene Oi‐Lin Ng(University of Hong Kong), Jing‐Ping Yun(Ministry of Agriculture and Rural Affairs), Eunice Y. Lau(Queen Elizabeth Hospital), Hua Yu(Shanghai Jiao Tong University), Carmen Oi Ning Leung(Hong Kong Polytechnic University), Shaohang Cai(Key Laboratory of Guangdong Province)
Cited by 53
Related Papers
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
|Cell stem cell|2018|723
Antidiabetic Potential of Medicinal Plants and Their Active Components
|Biomolecules|2019|721
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
|Nature Reviews Gastroenterology & Hepatology|2021|472
Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine
|Cancer Cell International|2022|454
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
|Cell Communication and Signaling|2024|359